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Abstract
Background: The 3D Cohort Study (Design, Develop, Discover) was established to help bridge knowledge gaps
about the links between various adverse exposures during pregnancy with birth outcomes and later health
outcomes in children.
Methods: Pregnant women and their partners were recruited during the first trimester from nine sites in Quebec
and followed along with their children through to 2 years of age. Questionnaires were administered during
pregnancy and post-delivery to collect information on demographics, mental health and life style, medical history,
psychosocial measures, diet, infant growth, and neurodevelopment. Information on the delivery and newborn
outcomes were abstracted from medical charts. Biological specimens were collected from mothers during each
trimester, fathers (once during the pregnancy), and infants (at delivery and 2 years of age) for storage in a
biological specimen bank.
Results: Of the 9864 women screened, 6348 met the eligibility criteria and 2366 women participated in the study
(37% of eligible women). Among women in the 3D cohort, 1721 of their partners (1704 biological fathers) agreed to
participate (73%). Two thousand two hundred and nineteen participants had a live singleton birth (94%). Prenatal
blood and urine samples as well as vaginal secretions were collected for ≥98% of participants, cord blood for 81%
of livebirths, and placental tissue for 89% of livebirths.
Conclusions: The 3D Cohort Study combines a rich bank of multiple biological specimens with extensive clinical,
life style, and psychosocial data. This data set is a valuable resource for studying the developmental etiology of
birth and early childhood neurodevelopmental outcomes.
Keywords: pregnancy cohort study, biological markers, infant development, adverse birth outcomes.
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Pregnancy is a foundation period for future health
and development. The etiologies of many adverse
birth outcomes are poorly understood, and there
remain important knowledge gaps concerning the
long-term impact of various adverse exposures dur-
ing pregnancy on later health outcomes in children.
Numerous environmental, nutritional, psychosocial,
and genetic factors have the potential to impinge on
a wide range of biological pathways and thus influ-
ence pregnancy and infant outcomes. Environmental,
nutritional factors, and psychosocial stress are
important potentially modifiable factors that hold
promise for developing effective prevention mea-
sures, and there appear to be critical windows of
vulnerability.1 Assessing the associations between
these exposures and pregnancy and infant health
outcomes presents major challenges. Multiple out-
comes may arise from a single exposure; different
exposures and their interactions may lead to a simi-
lar outcome; a given adverse outcome may occur
only in genetically susceptible individuals; and
dynamic temporal changes in the levels of exposures
may produce variable results.2 To address some of
these challenges, we developed a pregnancy and
birth cohort of 2366 pregnant women and their part-
ners (n = 1721) recruited in the first trimester in nine
Quebec clinical sites (seven sites in Montreal and one
each in Sherbrooke and Quebec City; Figure S1) and
followed at mid (20–24 weeks) and late (32–
35 weeks) gestation and at delivery. Mothers and
their children were followed postnatally through
2 years after the birth.
Objectives
The 3D Cohort Study (Design, Develop, Discover)
was established to address the intrauterine determi-
nants of important adverse birth outcomes including
intrauterine growth restriction (IUGR) and preterm
birth (PTB) and to study the links between exposures
during pregnancy and patterns of early childhood
development. The cohort study was also designed to
explore associations between exposure to assisted
reproductive technologies (ART) and maternal, fetal,
and child health outcomes. Through inclusion of data
on nutritional exposures, socio-economic and psy-
chosocial factors, genetic and epigenetic profiles, the
study has the potential to contribute to understanding
of developmental origins of metabolic and cardiovas-




The 3D Cohort Study is structured around a triadic
(mother-partner-child) framework. The cohort com-
prises 2366 women recruited in the first trimester of
pregnancy (8–14 weeks) who were planning to deli-
ver in a collaborating hospital in the province of
Quebec. Women and their partners were recruited
between May 25, 2010 and August 30, 2012 at one of
nine study centres during routine first-trimester pre-
natal visits to study hospitals and infertility clinics.
Women were between 18 and 47 years of age at the
time of recruitment and able to communicate in
French or English. Exclusion criteria included current
intravenous drug use, severe illnesses or life threaten-
ing conditions, and multiple gestation pregnancies.
Follow-up
Study follow-up was conducted by research nurses,
and infant follow-up was carried out by a team con-
sisting of a research nurse and research assistants
trained in developmental psychometrics. Following
recruitment in the first trimester, participants were
seen at mid (20–24 weeks) and late (32–35 weeks)
pregnancy, and at delivery. Postnatal visits took place
at 3 months, 1 year, and 2 years following the birth.
Data and biospecimen collection
Questionnaire data were collected prenatally and
postnatally and included maternal sociodemographic
characteristics, physical activity, and psychosocial
measures. We assessed nutritional exposures using a
3-day maternal food diary completed during the sec-
ond trimester. Data on the use of prescription drugs,
over-the-counter medications, and nutritional supple-
ments were collected through maternal and infant
medication logs. Maternal blood, vaginal swabs, and
urine samples were collected at each prenatal visit,
and prenatal toenail samples were collected between
32 and 35 weeks gestation. Obstetrical ultrasound
parameters were collected from examinations per-
formed as part of routine prenatal care. Blood and
urine samples were collected from the partners of
participating women prenatally (60% of samples
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collected at the first trimester visit, 24% at the second
trimester, 6% at the third trimester) or within 10 days
of the delivery (9%). At delivery cord blood, placenta
samples, meconium, and maternal and infant hair
samples were also collected.
Questionnaires
Exposures of interest were documented throughout
the pregnancy and postnatally using a questionnaire-
based approach that included: Maternal characteristics
(collected via interviewer-administered questionnaire):
maternal age, ethnicity, marital status, socio-economic
status (education, income, occupation), pre-pregnant
weight, inter pregnancy interval, pregnancy and med-
ical history, family medical history, mode of concep-
tion (ART procedures), time to conception, paternal
ethnicity, age, height, and weight. Measures collected
on individual and family medical history are shown
in Appendix S1. Maternal tobacco smoke (interviewer-
administered questionnaire): active and passive smoke
exposure. Participants’ postal codes were also col-
lected, allowing linkage to geographic data sources
with area-level measures of air pollutants, noise
levels, and proximity to green spaces. Nutritional expo-
sures: Consumption of nutritional supplements was
recorded in a medication and nutritional supplement
log at each prenatal visit (interviewer administered).
A 3-day food record and dietary habits questionnaire
was given to participants at the second trimester visit
and completed between 20 and 24 weeks gestation.
The 3-day food record allows the estimation of con-
sumption of energy, macronutrients (carbohydrates –
including fibres; lipids – total and different types of
lipids; and proteins), and micronutrients (vitamins
and minerals). An infant feeding and nutrition ques-
tionnaire was completed by interview at 3 months
and 12 months postpartum to assess the initiation,
duration and exclusivity of breast feeding and the age
of introduction of complementary foods. An infant
food diary was also completed over 3 days at
24 months. Medications: Maternal exposures to pre-
scription and non-prescription medications were
recorded via interviewer-administered questionnaire
for the periods before pregnancy (retrospective recall
by the mother in the 3 months before pregnancy) as
well as during each of the three trimesters (prospec-
tive measures). The same was done for the children at
3, 12 and 24 months of age. Detailed information was
collected including drug name, indication, dosage,
frequency and route of administration, and total
duration of use (Appendix S2). Psychosocial measures
were assessed by self-administered questionnaires
both prenatally and postnatally (questionnaires given
to participants at study visits and returned by post, or
completed by participants directly by Internet). Psy-
chosocial measures assessed included perceived
stress,3 pregnancy-related anxiety,4 depression,5 and
personality traits including self-esteem,6 dispositional
optimism7 and attachment8. Psychosocial measure-
ments including perceived stress,3 depression,5 self-
esteem,6 and marital strain9 were also assessed on
participating maternal partners (Table S2).
Infant follow-up
Follow-up of 3D infants was performed at 3, 12, and
24 months of age and completed in February 2015.
Visits were scheduled at the study centres (one centre
for each city: Montreal, Quebec, Sherbrooke), and
detailed sociodemographic, psychosocial, and nutri-
tional questionnaires were administered to the parent
(Table 2). Visits included assessment of child
behaviour and temperament, neurodevelopment,10
sensory profile,11 language development,12 and a
standardised growth assessment: weight, height, arm
length, back and arm skinfold thickness, crown-rump
length, and head, arm and waist circumference
(Table 4). Information collected on child health prob-
lems is detailed in Appendix S3. Blood and urine were
collected by a nurse at the 2-year visit.
Sample size and power calculation
The sample size that was initially targeted was
n = 3000. This sample size would have provided 96%
power to detect associations of relative risks of 2.0 or
greater with a baseline exposure rate of 20%. For
bivariate linear regression analyses, the sample size
would have provided 80% power to detect a change
in standardized regression coefficient from b = 0.5
under the null hypothesis to b = 0.543 under the alter-
native hypothesis, and 95% power to detect a change
in standardized regression coefficient b from 0.5 to
0.555. Due to delays in obtaining ethics approval,
recruitment begun later than planned, and it was nec-
essary to terminate recruitment before the target sam-
ple size of 3000 participants had been achieved in
order to complete postnatal follow-up within the
study’s funding cycle.
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Ethical considerations and governance
The research protocol, questionnaires, consent forms,
and recruitment posters and pamphlets were
reviewed and approved by human studies research
ethics committees, including the research ethics com-
mittee at the coordinating centre at Sainte-Justine’s
Hospital in Montreal, as well as academic and hospi-
tal ethics committees at all participating study sites.
Participants could partially (data and biospecimens
retained) or completely (all data and biospecimens
destroyed) withdraw from the study at any time.
The 3D Cohort Study’s governance structure
includes an executive committee, scientific committee,
and external advisory committee, which have five key
functions: (i) Intelligence gathering; (ii) Formulating
mission and vision, goals and objectives; (iii) Resour-
cing and implementation; (iv) Promoting collaborative
relationships; and (v) Controlling and monitoring the
achievement of policy goals.
Results
A total of 9864 women were approached at early
(<14 weeks) prenatal clinics, 6348 were eligible and
2456 agreed to participate (39%) (Figure S2). Forty-
seven women were later determined to be ineligible
and 43 withdrew completely from the study, asking
that all their data and biospecimens be destroyed. The
most common reasons for ineligibility were: not being
within the gestational age window (25% of ineligible
women), not planning to deliver in a participating
facility (23%), planning to deposit cord blood in
another biobank (16%), evidence of fetal demise
(16%), participation in another research project (6%),
not speaking or understanding French or English
(6%), and multifetal pregnancy (6%). Other reasons
each accounting for fewer than 1% of ineligible
women were age less than 18 years, cancer, cardiovas-
cular disease, connective tissue disease, epilepsy,
HIV, illicit drug use, severe haemoglobinopathy, sev-
ere pulmonary disease, and severe renal disease. Of
the 43 complete withdrawals, 33 participants reported
a specific reason for withdrawing from the study: 18
participants cited lack of interest in continuing in the
study, eight cited lack of time for the study, and seven
reported being convinced by their partner to with-
draw from the study. Demographic characteristics
concerning women who declined to participate were
not documented.
The mean gestational age at recruitment was
11.6  1.8 weeks. Table 1 shows the characteristics of
the study sample, along with similar descriptions for
Canadian births overall, the Canadian Health Mea-
sures Survey (CHMS), and overall births in the pro-
vince of Quebec. The baseline sociodemographic
questionnaires were well-responded to in the 3D
Study, with the highest refusal or ‘don’t know’
responses for family income (5.0%). Our study sample
is on average both older and of lower parity than
Canadian and Quebec births overall. The study also
has a higher percentage of mothers born outside of
Canada (35%). Compared to Canadian births overall,
Quebec births, and the CHMS, the 3D Study sample
was substantially more likely to have a university
degree (more than 60% of participants), and more
than 90% of participants were married or living with a
partner. Finally, the household income level was rela-
tively high, with more than half the study sample
reporting annual household income of greater than
$80 000. 14.6% of participants had a before taxes
household income below Statistics Canada’s before-
tax low-income cut-off for their family size,13 similar
to the 2010 national norm of 13.7%.
Table 2 shows additional demographic and health
measures assessed, as well as self-reported psychoso-
cial measurements. The prenatal food diary was
completed by 1550 women (66%). Prenatal self-
administered questionnaires containing psychosocial
measurements were completed by 1866 participants
(79%) at visit 1, 1725 (73%) at visit 2, and 1598 (68%) at
visit 3. Ultrasound assessments were conducted on
2032 women in the first trimester before 14 weeks,
2256 in the second trimester between 14 and
28 weeks, and 1833 in the third trimester between 28
and 37 weeks. One thousand seven hundred and
twenty one participants’ partners (1704 biological
fathers) agreed to participate (73%), and 2219 partici-
pants had a live singleton birth (94%).
Biological specimens collected are listed in Table 3.
Maternal blood samples were collected for at least
one prenatal visit from 2343 participants (99%) [all
three prenatal visits: 1870 participants (79%)], urine
samples for at least one prenatal visit from 2351
(99%) [all three prenatal visits: 1923 participants
(81%)], vaginal secretions for at least one prenatal
visit 2320 (98%) [both first- and second-trimester pre-
natal visits: 1949 participants (82%)], hair samples for
1956 (83%), cord blood for 1787 (81% of livebirths),
placental tissue for 1978 (89%), infant urine or blood
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Table 1. Comparison of 3D Study participants with data on Canadian births (2010) and female participants in the biomonitoring












Parity (%): Number of previous viable pregnancies
0 54.2% 43.3% 49.7% (41.5, 57.9) 44.4%
1 32.8% 35.3% 16.7% (12.8, 20.6) 35.8%
2 10.0% 13.8% 25.0% (17.2, 32.7) 13.6%
3+ 3.0% 7.5% 8.6% (5.2, 12.1)b 6.1%
Maternal age (%) (years)
<20c 0.4% 3.9% 2.7%
20–24 6.9% 14.6% 13.7%
25–29 31.8% 30.3% 33.5%
30–34 38.9% 32.3% 33.6%
35+ 22.0% 18.9% 16.4%
Mean age (years) (SD) 31.0 (4.7) 29.6 29.9 (29.0, 30.8) 30.0
Gestational age (weeks)
Mean (SD) 39.2 (2.2)
Median 39.6
Preterm birth (%): <37 weeks 6.7% 7.8% 7.2%
Birthweight (g)
Mean (SD) 3332 (583) 3358
Median 3370 3386
Low birthweight (<2500 g) (%) 5.1% 6.2% 5.7%
Mother born in Canada (%) 65.1% 72.9% 77.8% (67.6, 88.1) 78.3%
Infant gender (%)
Male 50.2% 51.3% 51.2%
Female 49.8% 48.7% 48.8%
Maternal education (%) d Highest level of
education in
household
High school or less 9.5% 26.8% 10.7% (4.6, 16.8)b 36.5%
Some college 1.5% 7.9% (3.3, 12.6)b
College diploma 26.7% 37.0% 38.9% (30.0, 47.9) 24.7%
University degree 62.3% 35.1% 42.4% (28.4, 56.5) 38.8%
Marital status of mother (%)
Married 94.5%e 60.4% 58.7% (51.4, 66.1) 36.9%
Divorced 0.6% 0.9% 1.4% (0.7, 2.1)b 1.2%
Separated 0.5% 0.4% 2.1% (0.6, 3.5)b 0.3%
Single 4.2% 27.5% 37.8% (30.5, 45.0) 59.1%
Other/Unknown 0.3% 10.9% f 2.5%
Fetal death (≥20 weeks) (% of total births) 0.8% 0.7%






Never 65.9% 89.5% did
not smoke
59.9% (52.7, 67.0) 89.1% did not
smoke
Former 19.8% 19.3% (15.4, 23.1)
Current smoker 14.3% 10.5% 20.8% (16.2, 25.5) 10.9%
Body mass index (kg/m2)
Underweight (<18.50) 6.0% 5.3% (2.1, 8.6)b
Normal (18.50–24.99) 63.3% 50.4% (39.8, 60.9)
Overweight (25.00–29.99) 18.4% 23.3% (16.2, 30.5)
Obese (>29.99) 12.3% 20.9% (15.6, 26.3)
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for 1010 (46% of livebirths), paternal blood for 1570
(92% of participating biological fathers) and paternal
urine for 1660 (97%). Protocol deviations in specimen
handling were reported for 5% of total maternal/
paternal blood samples taken, 20% of cord blood
samples, 3% of maternal/paternal urine samples, and
10% of vaginal secretions. The majority of protocol
deviations (82% for urine samples and >90% for all
other samples) were due to delays in freezing
(greater than 30 min for vaginal secretions or greater
than 2 h for all other samples). We have begun a pro-
cess of micro-aliquoting of the biological specimens.
A total of 278 participants used assisted reproduc-
tive technologies for the study pregnancy. Of these,
203 women used ovarian stimulation, 89 intrauterine
insemination, 133 in vitro fertilization, and seven
in vitro oocyte maturation.
Infant follow-up has been completed to 2-years of
age, with 1732 3-month visits completed, 1617 1-year
visits, and 1622 visits at 2 years of age (Figure S2).
Child health and developmental measures are
detailed in Table 4.
Comment
In the light of its breadth and quality of data col-
lected, the 3D Study has the potential to yield major
advances in diverse areas of perinatal research. While
several other existing birth cohorts approach or
exceed the size of the 3D Study,2,14–17 the combination
of extensive maternal psychosocial measures, serial
collection of biological specimens, and measurement
of child developmental outcomes sets the 3D Study
apart in terms of the research questions that can be
addressed.
The 3D cohort includes one of the largest and most
comprehensive biological specimen banks of any
Canadian birth cohort. Specimens have been ali-
quoted into several separate samples for analysis, and
we have begun a process of micro-aliquoting samples
such that specimens will be thawed and re-frozen
(80°C) a maximum of once. The biobank includes
whole blood, plasma, and blood cells from maternal,
partner, and cord blood. The extensive biobank and
high participation rates in this component of the study
make the 3D cohort an ideal resource for emerging
bio-specimens analysis techniques such as measure-
ment of cortisol levels in hair samples,18 epigenetic
measurements,19 and -omics technologies.20,21 Bio-
marker analyses currently planned or underway
include measurement of cotinine, corticotropin-releas-
ing hormone (CRH), vitamin D, fatty acids, and mark-
ers of inflammation, oxidative stress, and metabolic













Household income from all sourcesg
<$20 000 5.6% 10.7% (5.4, 16.0)b
$20 000–30 000 5.2% 5.0% (2.7, 7.3)b
$30 001–40 000 6.1% 9.0% (4.0, 13.9)b
$40 001–50 000 6.0% 9.3% (5.0, 13.6)b
$50 001–60 000 7.0% 9.8% (6.6. 13.0)
$60 001–80 000 17.2% 18.2% (14.5, 21.8)
$80 001–100 000 18.9% 9.6% (4.3, 14.9)b
>$100 000 29.1% 20.6% (16.1, 25.1)
No response 5.0% 7.8% (3.7, 12.0)b
aEstimates weighted for the CHMS complex survey design.
bHigh sampling variability associated with these estimates. Results should be interpreted with caution.
cLowest age category defined as 18 to <20 for 3D and under 20 years for Canadian births and Quebec births.
dSource: Reference27, 2006–07.
eMarried category includes domestic partnerships for 3D Study.
fEstimates of unacceptable quality and suppressed by Statistics Canada.
g$1 difference in categories between 3D and Statistics Canada.
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of psychosocial measures will enable validation of
these exposures with related biomarkers. The study
includes extensive psychosocial data and biological
specimens collected from mothers’ partners. With
more than 1700 partners participating, the 3D cohort
is a major resource for studying emerging research













postpartum 1 year 2 years
Medical history X
Vaccination X X X
Family medical history X
Self-reported pregnancy complications X X X
Infertility, time to pregnancy X
Use of assisted reproductive
technologies or ovulation inducing
drugs for study pregnancy
X
Medication, nutrition supplements X X X X
Smokinga X X X X X X
Alcohol consumption X X X X X
Coffee, tea, energy drinks X X X
Illicit drug use X X X X X
Employment status X X X X
Neighbourhood and financial support X
Self-reported environmental
exposuresb
X X X X
Sociodemographic characteristics X X X
Anthropometric measurements X X X
3-day food diary X






Pregnancy chart review X
Physical activity28 X X X
Pittsburgh Sleep Quality Index29 X X X
Perceived Stress Scale3 X X X X X X
Pregnancy anxiety measure4 X X X
Quality Marriage Index30 X X X X X X
Marital strain scale9 X X X
Center for Epidemiological Studies
Depression Scale5
X X X X X X
Job stress or control scale31 X
Food insecurity X X X X X X
Prenatal Life Events Scale32 Xc Xc
Life Orientation Test7 X
Self-esteem scale6 X X







aPrenatal smoking measurements include maternal exposure to first-hand, second-hand, and third-hand smoke; postnatal measure-
ments include maternal exposure to first-hand and second-hand smoke, and exposure of child to second-hand smoke.
bSelf-reported environmental exposures include use of hair products, nail care products, makeup, skincare products, sunscreen, and
fragrances.
cPrenatal life events scale administered at second-trimester visit with reference to the timeframe since the beginning of the pregnancy,
and at 2-year postnatal visit with reference to the timeframe since the delivery.
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(32–35 weeks) Delivery/48 h postpartum 2 years
Mother
Urine X X X
Blood X X X X














The 3-month and 1-year postnatal visits did not include biological specimens collection.
Table 4. Child health and developmental measurements assessed in the 3D Cohort Study
3 months
postpartum 1 year 2 years
Vaccination X
Health problems X X X
Special education services X
Injuries X
Hospitalization X X X
Medication, nutrition supplements X X X
Breast feeding and nutrition X X Nutrition items, food frequency
questionnaire, 3-day food diary
Mother–baby relationship33 X X X
Father–baby relationship33 X X X
Visual testing X
Teller acuity cards X
Auditory testing X
Electrophysiological testing X X
Anthropomorphic measurements X X X
Sleep pattern X
Maternal-reported environmental exposures X X
Child care X X
Language exposure X
General child behaviour X
Infant Characteristics Questionnaire (ICQ)34 X
Bayley Scales of Infant and Toddler Development (BSID-III)10 X
Bayley Adaptive Behaviour Questionnaire (ABAS-II)10 X
Sensory Profile 211 X
MacArthur Communicative Development Inventories (CDI)12 X
Modified Checklist of Autism in Toddlers (M-CHAT)35 X
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topics on issues such as paternal psychosocial expo-
sures22 and family based genetic studies.23
As mentioned above, the final sample size was
lower than the initial goal of 3000 because of admin-
istrative delays, thus the study power was somewhat
reduced compared to that of the target sample size.
The participation rate of 37% is consistent with par-
ticipation rates of several large pregnancy cohorts.24
As in other pregnancy cohort studies,15 3D Study
participants tended to be older and of higher socio-
economic status than the overall Canadian25 and
Quebec26 populations giving birth in 2010. Response
rates for psychosocial measures collected from self-
administered questionnaires (68–79%) were some-
what modest. Participation in postnatal follow-up
(1622 (73% of livebirths) at 24 months of age) was
also relatively moderate. Those who responded to
self-administered questionnaires and who partici-
pated in postnatal follow-up visits tended to be
older, of lower parity, had higher household
incomes and education levels, and were less likely to
smoke. Combined with the relatively high socio-eco-
nomic status of the study population, these differen-
tial response rates are likely to limit generalizability
of results from this cohort, particularly in psychoso-
cial and developmental domains. In addition, the
cohort was recruited from urban clinical centres in
three of the four largest metropolitan areas in the
province, and generalizability to rural populations
may also be limited.
In summary, principal strengths of the 3D Cohort
Study include the rich biological specimen collection,
availability of numerous medical and psychosocial
measures collected from mothers, fathers, and
children, as well as child neurodevelopmental assess-
ment. Contingent on funding of longer term follow-
up, the study has the potential to make important
contributions to understanding of developmental ori-
gins of metabolic and cardiovascular risks. Challenges
include limits to generalizability and administrative
coordination required to maintain postnatal follow-up
and to support the biobank.
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